Ribociclib 200mgTablet
Anti-Cancer

Ribociclib 200mg

Ribociclib Succinate

Selective CDK4/6 inhibitor for HR+/HER2- advanced breast cancer in combination with aromatase inhibitors or fulvestrant. Natco manufactures affordable generics for global oncology export.

Strengths

200mg

Packing

63 tablets/pack

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Ribociclib Succinate 200mg
Dosage Form
Tablet
Available Strengths
200mg
Packing
63 tablets/pack
Route of Administration
Oral, with or without food
Dosage
600mg (three 200mg tablets) once daily for 21 consecutive days followed by 7 days off in 28-day cycles
Indications
HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C
Shelf Life
36 months
Side Effects
Neutropenia, nausea, fatigue, diarrhea, alopecia, QTc prolongation, hepatotoxicity
Precautions
ECG monitoring for QTc prolongation; liver function tests before and during treatment; CBC monitoring for neutropenia; avoid strong CYP3A4 inhibitors

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Ribociclib 200mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote